Arthritis Drugs Show How U.S. Drug Prices Defy Economics
Drugs that treat rheumatoid arthritis started out costing about $10,000 a year. Ten years later, they list for more than $40,000.
Health Industry
2,301 - 2,320 of 3,881 Results
-
-
Biosimilars, Biologics And New Legal Challenges For RA Treatments
As biosimilar products reach the market and rival more established RA treatments, the players are exploring legal challenges involving antitrust and anti-competitive behavior.
-
-
Medicare Penalizes Group Of 751 Hospitals For Patient Injuries
Each hospital will have its payments reduced by 1 percent for the year.
By Jordan Rau -
Unregulated Herpes Experiments Expose 鈥楤lack Hole鈥 Of Accountability
Controversial research methods by university researcher unlikely to prompt federal response or institutional change, experts say.
-
Doing More Harm Than Good? Epidemic of Screening Burdens Nation鈥檚 Older Patients
Patients are often aggressively screened for cancer, even if they won鈥檛 live long enough to benefit.
By Liz Szabo -
Drug Industry Spent Millions To Squelch Talk About High Drug Prices
Last year, the pharma industry鈥 biggest trade group raised millions to change the conversation about drug pricing.
By Jay Hancock -
No Sweeteners Added To Tax Bill To Spread Use Of Health Savings Accounts
These accounts are exempt from taxes and linked to high-deductible health plans. Republicans tried last summer in their unsuccessful efforts to replace the health law to make the accounts more enticing for consumers, but they didn鈥檛 make those changes in the current tax bill.
-
Canada鈥檚 Single-Payer Health System: What Is True? What Is False?
It鈥檚 a regular part of the politically charged debate over health care. But the lines sometimes blur between rhetoric and how Canada鈥檚 system actually works.
-
Looking North: Can A Single-Payer Health System Work In The U.S.?
American single-payer advocates want to emulate Canada鈥檚 system. But many Canadian experts say the U.S. first needs to address some basic questions.
-
Medicare Fails To Recover Hundreds Of Millions Of Dollars In Lab Overcharges
Genetic testing firms declare bankruptcy and wipe out debt to the federal government.
By Fred Schulte -
In Era Of Increased Competition, Hospitals Fret Over Ratings
Hospitals are jockeying for patients and view the many different quality and safety ratings as a keen way to distinguish their services. But when those ratings nosedive, a hospital may retaliate.
By Jenny Gold -
Opioids After Surgery Left Her Addicted. Is That A Medical Error?
Doctors prescribed powerful opioids for a patient after back surgery but gave her little guidance on how to take them safely. Then, she says, they misdiagnosed her withdrawal symptoms. Some experts say this situation is akin to a hospital-acquired condition.
-
Stopping Opioid Addiction At One Key Source: The Hospital
Based on research conducted at the University of Michigan鈥檚 medical center, a group of surgeons developed a strategy to help post-surgical patients from misusing or abusing their prescription painkillers.
-
Your Plumber Offers A Money-Back Guarantee. Should Your Doctor?
Even though consumers don鈥檛 expect to pay for faulty service or goods, they are often forced to pay for bad health care. But a small number of hospitals and doctors are seeking to change that practice.
-
CVS-Aetna Merger A Bid To Bring Down Costs, Gain Competitive Edge
What will the mega-merger mean for consumers and the health care industry? Senior correspondent Chad Terhune offers insight.
-
Whistleblower: Medicaid Managed-Care Firm Improperly Denied Care To Thousands
An explosive report prepared by a SynerMed executive alleges the California firm, which oversaw care for 1.2 million patients, fabricated documents and violated state and federal regulations for years. The state says it left low-income patients on Medicaid managed care in 鈥渋mminent danger.鈥
By Chad Terhune -
If Your Insurer Covers Few Therapists, Is That Really Mental Health Parity?
Behavioral care was four times more likely to be out-of-network than medical or surgical care, an analysis by Milliman shows.
By Jenny Gold -
Hospitals With History Get A Second Life
The number of hospitals across the country has plummeted, but many old buildings are being resuscitated as apartments and condos.
By Phil Galewitz and Anna Gorman -
Patients With Rare Diseases And Congress Square Off Over Orphan Drug Tax Credits
The House and Senate want to reduce or eliminate federal tax credits for 鈥渙rphan drugs鈥 used to treat rare diseases, but patients are fighting against the plan.